📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Camk2n1 Is a Negative Regulator of Blood Pressure, Left Ventricular Mass, Insulin Sensitivity, and Promotes Adiposity. (2019)

First Author: Alfazema N

Attributed to: Edinburgh-St Andrews Consortium for Molecular Pathology, Informatics and Genome Sciences funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1161/hypertensionaha.118.12409

PubMed Identifier: 31327268

Publication URI: http://europepmc.org/abstract/MED/31327268

Type: Journal Article/Review

Volume: 74

Parent Publication: Hypertension (Dallas, Tex. : 1979)

Issue: 3

ISSN: 0194-911X